Related Experiment Video
Updated: Aug 10, 2026
11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Tailoring tacrolimus-based immunotherapy in renal transplantation
1Pinnacle Health Systems at Harrisburg, Harrisburg, Pennsylvania 17104-1696, USA. hyang@pinnaclehealth.org
Summary
Tacrolimus-based immunosuppression, combined with mycophenolate mofetil (MMF) or sirolimus, improves renal transplant outcomes. These regimens offer better graft survival and function compared to older treatments, optimizing long-term graft health.
Area of Science:
- Nephrology
- Immunology
- Transplantation Medicine
Background:
- Tacrolimus is a key immunosuppressant in renal transplantation, offering advantages over cyclosporine by reducing acute rejection.
- Optimizing early post-transplant immunosuppression is crucial for long-term graft survival and function.
- Novel combinations with mycophenolate mofetil (MMF) and sirolimus are being explored to enhance outcomes.
Purpose of the Study:
- To evaluate the efficacy of tacrolimus combined with MMF or sirolimus in renal transplantation.
- To compare these novel regimens against established immunosuppressive protocols.
Main Methods:
- Review of clinical studies comparing tacrolimus-MMF and tacrolimus-sirolimus regimens.
- Analysis of patient and graft survival, acute rejection rates, graft function, and adverse events.
Main Results:
- Tacrolimus-MMF demonstrated superior graft survival and renal function at 3 years compared to cyclosporine-MMF, especially in patients with delayed graft function.
- Tacrolimus-MMF also showed excellent 1-year survival and rejection rates in a US multicenter study.
- Tacrolimus-MMF and tacrolimus-sirolimus showed comparable efficacy in patient/graft survival and acute rejection at 3 months, with noted differences in acute tubular necrosis and hyperlipidemia.
Conclusions:
- Tacrolimus combined with MMF or sirolimus represents an effective strategy for improving renal transplant outcomes.
- Regimen selection should consider factors influencing both short-term and long-term graft function for personalized therapy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...